In NSCLC, Cai et al. (2017) and Jin et al. (2020) reported that high expression of DSG2 was associated with unfavorable prognosis and a negative correlation between DSG2 expression and prognosis was also found by Han et al. (2018) in hepatocellular carcinoma. This evidence concerns the gene DSG2 and non-small cell lung carcinoma.